Screener
Rhythm Pharmaceuticals, Inc. RYTM Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Intangible assets, net | 5,106 | 5,319 |
| Restricted cash | 601 | 522 |
| Other long-term assets | 2,518 | 3,286 |
| Total assets | $442,316 | $480,196 |
| Liabilities, Convertible Preferred Stock and Stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $12,299 | $13,947 |
| Accrued expenses and other current liabilities | 80,045 | 83,855 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s total assets?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported total assets of $442.32M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s total assets changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s total assets increased by 14.4% year-over-year, from $386.69M to $442.32M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s total assets?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s total assets has grown at a 20.7% compound annual growth rate (CAGR), from $187.07M to $480.2M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude